Gaia, Inc. (GAIA) At $12.15 Forms Top; WINDTREE THERAPEUTICS (WINT) Sellers Decreased By 42.08% Their Shorts

Gaia, Inc. (GAIA) formed multiple top with $12.51 target or 3.00% above today’s $12.15 share price. Gaia, Inc. (GAIA) has $184.29 million valuation. The stock increased 2.10% or $0.25 during the last trading session, reaching $12.15. About 20,974 shares traded. Gaia, Inc. (NASDAQ:GAIA) has risen 39.47% since January 5, 2017 and is uptrending. It has outperformed by 22.77% the S&P500.

WINDTREE THERAPEUTICS INCORPORATED (NASDAQ:WINT) had a decrease of 42.08% in short interest. WINT’s SI was 53,400 shares in January as released by FINRA. Its down 42.08% from 92,200 shares previously. With 86,200 avg volume, 1 days are for WINDTREE THERAPEUTICS INCORPORATED (NASDAQ:WINT)’s short sellers to cover WINT’s short positions. The stock decreased 8.29% or $0.0236 during the last trading session, reaching $0.2612. About shares traded. Windtree Therapeutics, Inc. (NASDAQ:WINT) has 0.00% since January 5, 2017 and is . It has underperformed by 16.70% the S&P500.

Windtree Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel surfactant therapies for respiratory diseases and other potential applications. The company has market cap of $16.51 million. The Company’s proprietary technology platform includes a synthetic peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. It currently has negative earnings. The companyÂ’s lead development program comprises AEROSURF, a drug/device product that is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: